Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 1013116 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
        1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
        1.2.4 Entry and Fusion Inhibitors
        1.2.5 Protease Inhibitors (PIs)
        1.2.6 Integrase Inhibitors
        1.2.7 Coreceptor Antagonists
    1.3 Market by Application
        1.3.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Labs
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Perspective (2016-2027)
    2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Growth Trends by Regions
        2.2.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Industry Dynamic
        2.3.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Trends
        2.3.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Drivers
        2.3.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Challenges
        2.3.4 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players by Revenue
        3.1.1 Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue
    3.4 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Concentration Ratio
        3.4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in 2020
    3.5 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players Head office and Area Served
    3.6 Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Solution and Service
    3.7 Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Human Immunodeficiency Virus (HIV)-1 Therapeutics Breakdown Data by Type
    4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Type (2022-2027)

5 Human Immunodeficiency Virus (HIV)-1 Therapeutics Breakdown Data by Application
    5.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2027)
    6.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
        6.2.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2027)
    6.3 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
        6.3.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2027)
    6.4 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
        6.4.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2027)
    7.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
        7.2.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
        7.3.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
        7.4.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2027)
    9.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
        9.2.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
        9.3.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
        9.4.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie, Inc.(U.S.)
        11.1.1 AbbVie, Inc.(U.S.) Company Details
        11.1.2 AbbVie, Inc.(U.S.) Business Overview
        11.1.3 AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
        11.1.4 AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
        11.1.5 AbbVie, Inc.(U.S.) Recent Development
    11.2 Merck & Co., Inc. (U.S.)
        11.2.1 Merck & Co., Inc. (U.S.) Company Details
        11.2.2 Merck & Co., Inc. (U.S.) Business Overview
        11.2.3 Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
        11.2.4 Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
        11.2.5 Merck & Co., Inc. (U.S.) Recent Development
    11.3 Bristol-Myers Squibb Company (U.S.)
        11.3.1 Bristol-Myers Squibb Company (U.S.) Company Details
        11.3.2 Bristol-Myers Squibb Company (U.S.) Business Overview
        11.3.3 Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
        11.3.4 Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
        11.3.5 Bristol-Myers Squibb Company (U.S.) Recent Development
    11.4 Boehringer Ingelheim GmbH (Germany)
        11.4.1 Boehringer Ingelheim GmbH (Germany) Company Details
        11.4.2 Boehringer Ingelheim GmbH (Germany) Business Overview
        11.4.3 Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
        11.4.4 Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
        11.4.5 Boehringer Ingelheim GmbH (Germany) Recent Development
    11.5 Genentech, Inc. (U.S.)
        11.5.1 Genentech, Inc. (U.S.) Company Details
        11.5.2 Genentech, Inc. (U.S.) Business Overview
        11.5.3 Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
        11.5.4 Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
        11.5.5 Genentech, Inc. (U.S.) Recent Development
    11.6 Cipla, Inc. (India)
        11.6.1 Cipla, Inc. (India) Company Details
        11.6.2 Cipla, Inc. (India) Business Overview
        11.6.3 Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
        11.6.4 Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
        11.6.5 Cipla, Inc. (India) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
    Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    Table 4. Key Players of Entry and Fusion Inhibitors
    Table 5. Key Players of Protease Inhibitors (PIs)
    Table 6. Key Players of Integrase Inhibitors
    Table 7. Key Players of Coreceptor Antagonists
    Table 8. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions (2016-2021)
    Table 12. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions (2022-2027)
    Table 14. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Trends
    Table 15. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Drivers
    Table 16. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Challenges
    Table 17. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Restraints
    Table 18. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Players (2016-2021)
    Table 20. Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics as of 2020)
    Table 21. Ranking of Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Solution and Service
    Table 25. Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Type (2016-2021)
    Table 29. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Application (2016-2021)
    Table 33. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. AbbVie, Inc.(U.S.) Company Details
    Table 66. AbbVie, Inc.(U.S.) Business Overview
    Table 67. AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
    Table 68. AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021) & (US$ Million)
    Table 69. AbbVie, Inc.(U.S.) Recent Development
    Table 70. Merck & Co., Inc. (U.S.) Company Details
    Table 71. Merck & Co., Inc. (U.S.) Business Overview
    Table 72. Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
    Table 73. Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021) & (US$ Million)
    Table 74. Merck & Co., Inc. (U.S.) Recent Development
    Table 75. Bristol-Myers Squibb Company (U.S.) Company Details
    Table 76. Bristol-Myers Squibb Company (U.S.) Business Overview
    Table 77. Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
    Table 78. Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021) & (US$ Million)
    Table 79. Bristol-Myers Squibb Company (U.S.) Recent Development
    Table 80. Boehringer Ingelheim GmbH (Germany) Company Details
    Table 81. Boehringer Ingelheim GmbH (Germany) Business Overview
    Table 82. Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
    Table 83. Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021) & (US$ Million)
    Table 84. Boehringer Ingelheim GmbH (Germany) Recent Development
    Table 85. Genentech, Inc. (U.S.) Company Details
    Table 86. Genentech, Inc. (U.S.) Business Overview
    Table 87. Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
    Table 88. Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021) & (US$ Million)
    Table 89. Genentech, Inc. (U.S.) Recent Development
    Table 90. Cipla, Inc. (India) Company Details
    Table 91. Cipla, Inc. (India) Business Overview
    Table 92. Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
    Table 93. Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021) & (US$ Million)
    Table 94. Cipla, Inc. (India) Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features
    Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
    Figure 4. Entry and Fusion Inhibitors Features
    Figure 5. Protease Inhibitors (PIs) Features
    Figure 6. Integrase Inhibitors Features
    Figure 7. Coreceptor Antagonists Features
    Figure 8. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application: 2020 VS 2027
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Labs Case Studies
    Figure 12. Human Immunodeficiency Virus (HIV)-1 Therapeutics Report Years Considered
    Figure 13. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 16. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions (2022-2027)
    Figure 17. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Players in 2020
    Figure 18. Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in 2020
    Figure 20. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 21. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 22. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2027)
    Figure 24. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2027)
    Figure 25. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Country (2016-2027)
    Figure 26. United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2027)
    Figure 30. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2027)
    Figure 31. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Country (2016-2027)
    Figure 32. Germany Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Region (2016-2027)
    Figure 42. China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2027)
    Figure 50. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2027)
    Figure 51. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Country (2016-2027)
    Figure 52. Mexico Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Country (2016-2027)
    Figure 58. Turkey Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. AbbVie, Inc.(U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
    Figure 62. Merck & Co., Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
    Figure 63. Bristol-Myers Squibb Company (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
    Figure 64. Boehringer Ingelheim GmbH (Germany) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
    Figure 65. Genentech, Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
    Figure 66. Cipla, Inc. (India) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie, Inc.(U.S.)
Merck & Co., Inc. (U.S.)
Bristol-Myers Squibb Company (U.S.)
Boehringer Ingelheim GmbH (Germany)
Genentech, Inc. (U.S.)
Cipla, Inc. (India)
Frequently Asked Questions
Human Immunodeficiency Virus (HIV)-1 Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Immunodeficiency Virus (HIV)-1 Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Immunodeficiency Virus (HIV)-1 Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports